Results 111 to 120 of about 623,045 (205)

Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunity. [PDF]

Front Immunol, 2022
Juarez I, Su S, Herbert ZT, Teijaro JR, Moulton VR.   +4 more
europepmc   +1 more source

Heterogeneity of human anti-viral immunity shaped by virus, tissue, age, and sex. [PDF]

Cell Rep, 2021
Poon MML, Byington E, Meng W, Kubota M, Matsumoto R, Grifoni A, Weiskopf D, Dogra P, Lam N, Szabo PA, Ural BB, Wells SB, Rosenfeld AM, Brusko MA, Brusko TM, Connors TJ, Sette A, Sims PA, Luning Prak ET, Shen Y, Farber DL.   +20 more
europepmc   +1 more source

The Aryl Hydrocarbon Receptor as a Modulator of Anti-viral Immunity. [PDF]

Front Immunol, 2021
Torti MF, Giovannoni F, Quintana FJ, García CC.   +3 more
europepmc   +1 more source

High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines

BMC Infectious Diseases
Background SARS-CoV-2, the causative agent of COVID-19, is a betacoronavirus belonging to the same genus as endemic human coronaviruses (hCoVs) OC43 and HKU1 and is distinct from alpha hCoVs 229E and NL63. In a study of adolescents in the Philippines, we
Janet O. Joseph, Michelle Ylade, Jedas Veronica Daag, Rosemary Aogo, Maria Vinna Crisostomo, Patrick Mpingabo, Lakshmanane Premkumar, Jacqueline Deen, Leah C. Katzelnick   +8 more
doaj   +1 more source

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity. [PDF]

Viruses, 2021
Manske K, Schneider A, Ko C, Knolle PA, Steiger K, Protzer U, Wohlleber D.   +6 more
europepmc   +1 more source

Viral Immunity and Vaccines in Hematologic Malignancies: Implications for COVID-19. [PDF]

Blood Cancer Discov, 2021
Dhodapkar MV, Dhodapkar KM, Ahmed R.
europepmc   +1 more source

The New Kid on the Block: HLA-C, a Key Regulator of Natural Killer Cells in Viral Immunity. [PDF]

Cells, 2021
Vollmers S, Lobermeyer A, Körner C.
europepmc   +1 more source

Ezrin Peptide Therapy from HIV to COVID: Inhibition of Inflammation and Amplification of Adaptive Anti-Viral Immunity. [PDF]

Int J Mol Sci, 2021
Holms RD, Ataullakhanov RI.
europepmc   +1 more source

Structural basis of Blastomyces Endoglucanase-2 adjuvancy in anti-fungal and -viral immunity. [PDF]

PLoS Pathog, 2021
Dos Santos Dias L, Dobson HE, Bakke BK, Kujoth GC, Huang J, Kohn EM, Taira CL, Wang H, Supekar NT, Fites JS, Gates D, Gomez CL, Specht CA, Levitz SM, Azadi P, Li L, Suresh M, Klein BS, Wüthrich M.   +18 more
europepmc   +1 more source

Inhibitory immune checkpoints cause exhaustion of viral immunity in coronary artery disease. [PDF]

Nat Cardiovasc Res, 2022
europepmc   +1 more source